Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever ...

Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...

Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

The surge in MRNA stock comes after some SEC filings show that company insiders bought shares worth $6 million.

Moderna shares experienced a significant surge in trading on Thursday, posting a 5.58% gain in European markets and an impressive jump of up to 16% on the NASDAQ. This remarkable performance was ...

The pandemic's volatility affected all public companies, but some saw their business deeply transformed. Here's how three of ...

The leader of an iconic apparel company and the co-founder and chair of Moderna are the honored speakers for the Worcester ...

Enterprise AI company Dataiku released a survey of 500 CEOs and found that they're worried about losing their jobs — and soon ...

The 2020s have inarguably been Covid-19’s decade. Since the coronavirus outbreak was acknowledged as a pandemic exactly five ...